Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone

S. Bajusz, T. Janaky, V. J. Csernus, L. Bokser, M. Fekete, G. Srkalovic, T. W. Redding, A. V. Schally

Research output: Contribution to journalArticle

66 Scopus citations

Abstract

Metal complexes related to the cytotoxic complexes cisplatin [cis-diamminedichloroplatinum(II)] and trans-bis(salicylaldoximato)copper(II) were incorporated into suitably modified luteinizing hormone-releasing hormone (LH-RH) analogues containing D-lysine at position 6. Some of the metallopeptides thus obtained proved to be highly active LH-RH agonists or antagonists. For instance, SB-40, a PtCl2-containing metallopeptide in which platinum is coordinated to an N(ε)-(DL-2,3-diaminopropionyl)-D-lysine residue (D-Lys-DL-A2pr] at position 6, showed 50 times higher LH-releasing potency than the native hormone. SB-95, [Ac-D-Nal(2)1,D-Phe(pCl)2,D-Pal(3)2,Arg5-D-Lys{DL- A2pr(Sal2Cu)}6,D-la10]LH-RH, where Nal(2) is 3-(2-naphthyl)alanine, Pal(3) is 3-(3-pyridyl)alanine, and copper(II) is coordinated to the salicylideneimino moieties resulting from condensation of salicylaldehyde with D-Lys(DL-A2pr)6, caused 100% inhibition of ovulation at a dose of 3 μg in rats. Most metallopeptide analogues of LH-RH showed high affinities for the membrane receptors of rat pituitary and human breast cancer cells. Some of these metallopeptides had cytotoxic activity against human breast cancer and prostate cancer cell lines in vitro (this will be the subject of a separate paper on cytotoxicity evaluation). Such cytostatic metallopeptides could be envisioned as targeted chemotherapeutic agents in cancers that contain receptors for LH-RH-like peptides.

Original languageEnglish (US)
Pages (from-to)6313-6317
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume86
Issue number16
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone'. Together they form a unique fingerprint.

  • Cite this